Retrospective analysis of retail pharmacy prescription data from 1,776 patients taking a chronic cardiovascular medication between May 2008 and September 2009, revealed that Pleio GoodStart™ had a highly significant impact on medication adherence, resulting in patients refilling an average of two additional 30-day prescriptions during their initial 9-month period on the medication (p<0.001).
Data also showed that patients who participated in the GoodStart™ program refilled their prescriptions an average of ten days sooner than control group participants. Collectively, these data demonstrate a significant, sustained improvement in patient medication adherence with the Pleio GoodStart™ program.
"Improving people's experience with new prescription medications involves many disciplines. Pleio's technology, pharmacy and manufacturer partners are equally dedicated to improving the patient experience with new prescriptions. These results show that when elderly patients are carefully listened to, stimulated in language they can relate to, and empowered with performance support, adherence challenges are easily overcome."
Pleio GoodStart connects physicians, patients, pharmacies, families and pharmaceutical manufacturers toward their common goal of improved patient adherence. Physicians gain the assurance that their patients will be well-supported and that future patient appointments can be more effective. Pharmacies are provided a new perspective on C&P through training and feedback on patient progress. Patients receive unprecedented interest in their welfare throughout the medication adoption phase, with up to 75 contacts during their first 100 days on therapy. Family and friend support is stimulated through awareness of the issue of adherence and their potential to be an advocate.
Monday, October 26, 2009
Posted by Jean Lalonde at 6:36 PM